Wu Zhenchao, Yao Taikang, Han Zhongyu, Wang Zilu, Liu Beibei, Lu Ming, Zheng Jiajia, Shen Ning
Department of Pulmonary and Critical Care Medicine Peking University Third Hospital Beijing People's Republic of China.
Department of Laboratory Medicine Peking University Third Hospital Beijing People's Republic of China.
Food Sci Nutr. 2025 Jun 10;13(6):e70422. doi: 10.1002/fsn3.70422. eCollection 2025 Jun.
Recent studies showed ferritin increase and hemoglobin decrease to COVID-19 severity and sepsis mortality. However, the potential relationship between iron metabolism disorders and susceptibility to pneumonia remains unclear. This study explores the association between iron metabolism disorder and susceptibility to bacterial pneumonia, viral pneumonia, and sepsis. GWAS data from the FinnGen and UK biobank is used for a two-sample Mendelian randomization (MR) analysis, followed by MR meta-analysis. Low serum iron levels were negatively associated with the risk of bacterial pneumonia (OR, 0.85; = 0.04), influenza pneumonia (OR, 0.86; = 0.03), and sepsis (OR, 0.81; = 0.0004). Increased transferrin saturation and decreased total iron-binding capacity were linked to higher risks of bacterial pneumonia and sepsis. Elevated liver iron content correlated positively with susceptibility to bacterial pneumonia (OR, 1.11; = 0.007), influenza pneumonia (OR, 1.08; = 0.03), and sepsis (OR, 1.13; = 0.0007), but negatively with pneumococcal pneumonia (OR, 37.62; = 0.0013). Neutrophils mediated the impact of serum iron and transferrin saturation on susceptibility to bacterial pneumonia and sepsis. This MR study confirms that disruptions in iron metabolism, including low serum iron levels and elevated liver iron content, increase susceptibility to bacterial and viral pneumonia as well as sepsis by affecting neutrophil function and cytokine levels. The findings emphasize the need for monitoring iron metabolism indicators in high-risk populations and provide valuable insights for further mechanistic research and clinical intervention.
最近的研究表明,铁蛋白升高和血红蛋白降低与新冠肺炎的严重程度和脓毒症死亡率相关。然而,铁代谢紊乱与肺炎易感性之间的潜在关系仍不清楚。本研究探讨铁代谢紊乱与细菌性肺炎、病毒性肺炎和脓毒症易感性之间的关联。使用来自芬兰基因库(FinnGen)和英国生物银行的全基因组关联研究(GWAS)数据进行两样本孟德尔随机化(MR)分析,随后进行MR荟萃分析。低血清铁水平与细菌性肺炎风险(比值比[OR],0.85;P = 0.04)、流感肺炎风险(OR,0.86;P = 0.03)和脓毒症风险(OR,0.81;P = 0.0004)呈负相关。转铁蛋白饱和度增加和总铁结合能力降低与细菌性肺炎和脓毒症的较高风险相关。肝脏铁含量升高与细菌性肺炎易感性(OR,1.11;P = 0.007)、流感肺炎易感性(OR,1.08;P = 0.03)和脓毒症易感性(OR,1.13;P = 0.0007)呈正相关,但与肺炎球菌肺炎易感性呈负相关(OR,37.62;P = 0.0013)。中性粒细胞介导了血清铁和转铁蛋白饱和度对细菌性肺炎和脓毒症易感性的影响。这项MR研究证实,铁代谢紊乱,包括低血清铁水平和肝脏铁含量升高,通过影响中性粒细胞功能和细胞因子水平,增加了对细菌性和病毒性肺炎以及脓毒症的易感性。这些发现强调了在高危人群中监测铁代谢指标的必要性,并为进一步的机制研究和临床干预提供了有价值的见解。